4.5 Review

International Undiagnosed Diseases Programs (UDPs): components and outcomes

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

I am not a number! Opinions and preferences of people with intellectual disability about genetic healthcare

Iva Strnadova et al.

Summary: This study conducted in New South Wales, Australia explores the knowledge and experiences of genetic healthcare from the perspective of people with intellectual disability. Interviews were conducted with 18 adults with intellectual disability and 8 support people. The findings suggest inequitable access to genetic healthcare services, variable experiences and opinions, barriers in translating genetic diagnosis into appropriate support, high incidence of trauma exposure, and recommendations for a more inclusive model of genetic healthcare.

EUROPEAN JOURNAL OF HUMAN GENETICS (2023)

Review Biochemistry & Molecular Biology

A systematic review of geographical inequities for accessing clinical genomic and genetic services for non-cancer related rare disease

Stephanie Best et al.

Summary: The research highlights the significant impact of location on accessing genetic/genomic services. Challenges such as lack of genetic specialists in rural areas, need for more generalist services, and insufficient genetic/genomic knowledge are exacerbated for rural populations. Both rural and urban communities face common barriers, emphasizing the importance of raising awareness and knowledge among communities and clinicians.

EUROPEAN JOURNAL OF HUMAN GENETICS (2022)

Review Genetics & Heredity

Re-analysis of genomic data: An overview of the mechanisms and complexities of clinical adoption

Alan J. Robertson et al.

Summary: Re-analyzing genomic information from patients can enhance diagnostic yield of sequencing tests, but it comes with complexities and challenges such as terminology, increased workload, reimbursement pathways, and ethical implications. This review proposes a terminology, identifies mechanisms for increasing diagnostic yield, and provides insights into the challenges faced by healthcare systems and individual patients.

GENETICS IN MEDICINE (2022)

Article Genetics & Heredity

Outcome of over 1500 matches through the Matchmaker Exchange for rare disease gene discovery: The 2-year experience of Care4Rare Canada

Matthew Osmond et al.

Summary: Matchmaking through the Matchmaker Exchange (MME) is an effective approach for investigating novel candidate genes in rare diseases; however, it requires labor-intensive efforts and engagement from the community to ensure its usefulness in the future.

GENETICS IN MEDICINE (2022)

Article Genetics & Heredity

Artificial intelligence (AI)-assisted exome reanalysis greatly aids in the identification of new positive cases and reduces analysis time in a clinical diagnostic laboratory

Timothy D. O'Brien et al.

Summary: This study evaluated the feasibility of a commercial AI tool and an open-source variant prioritization tool in clinical diagnostics through validation and reanalysis of previous clinical cases. The results showed that the AI tool accurately selected causal variants and identified new positive cases, while the open-source tool also identified causal genes to some extent. The study demonstrates that the use of AI tools in diagnostic laboratories greatly enhances exome sequencing analysis efficiency.

GENETICS IN MEDICINE (2022)

Article Genetics & Heredity

Lessons learnt from multifaceted diagnostic approaches to the first 150 families in Victoria's Undiagnosed Diseases Program

Thomas Cloney et al.

Summary: This study shared the lessons learned from the first three years of the Undiagnosed Diseases Program in Victoria, Australia, highlighting the importance of flexible implementation of multiple strategies, utilizing family-based exome sequencing, and international data sharing strategies to improve diagnostic outcomes for individuals with rare diseases.

JOURNAL OF MEDICAL GENETICS (2022)

Article Genetics & Heredity

Undiagnosed disease program in South Africa: Results from first 100 exomes

Shahida Moosa et al.

Summary: The Undiagnosed Disease Program in South Africa used exome sequencing to clinically evaluate patients with suspected rare genetic disorders, and found that this method is valuable in diagnosing such disorders. Half of the patients were successfully diagnosed, and novel gene variants were discovered. Further research and gene discovery can be conducted for the remaining undiagnosed patients.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2022)

Article Pediatrics

Indian Undiagnosed Diseases Program (I-UDP) - The Unmet Need

Ratna Dua Puri et al.

Summary: Genomics plays a crucial role in pediatric diseases, but many patients still do not receive a definitive diagnosis despite current available genetic tests. The Indian Undiagnosed Diseases Program aims to address this gap by using collaborative effort, detailed phenotype, and patient-specific bioinformatics pipelines to build a diagnostic algorithm.

INDIAN PEDIATRICS (2022)

Article Genetics & Heredity

Six years' accomplishment of the Initiative on Rare and Undiagnosed Diseases: nationwide project in Japan to discover causes, mechanisms, and cures

Yuji Takahashi et al.

Summary: The identification of causative genetic variants for hereditary diseases has revolutionized clinical medicine, and international cooperation has become a global trend in understanding rare disorders. In Japan, the Initiative on Rare and Undiagnosed Diseases (IRUD) aims to accurately diagnose, discover causes, and provide cures for rare and undiagnosed diseases. The IRUD system consists of diagnostic coordination, analysis centers, and a data center, and has successfully established a comprehensive diagnostic and research system covering all of Japan's geographic areas and clinical specialties. The IRUD has accurately diagnosed diseases, identified novel genes and disease entities, and enriched databases.

JOURNAL OF HUMAN GENETICS (2022)

Review Endocrinology & Metabolism

Diagnosis and discovery: Insights from the NIH Undiagnosed Diseases Program

Carolina Montano et al.

Summary: Living with an undiagnosed medical condition is challenging for patients, their families, and healthcare providers. The Undiagnosed Diseases Program (UDP), established by the National Institutes of Health (NIH), aims to diagnose mysterious conditions and advance medical knowledge. Through clinical evaluations and genetic testing, the UDP investigates novel disease mechanisms and provides appropriate treatment. The UDP's network and international collaborations contribute to advancing our understanding of pathophysiology, accelerating accurate diagnoses, and improving patient care.

JOURNAL OF INHERITED METABOLIC DISEASE (2022)

Article Genetics & Heredity

Shortcutting the diagnostic odyssey: the multidisciplinary Program for Undiagnosed Rare Diseases in adults (UD-PrOZA)

Nika Schuermans et al.

Summary: UD-PrOZA is an innovative interdisciplinary platform for diagnosing rare diseases in adults and supporting translational research. It combines a multidisciplinary clinical approach with state-of-the-art genomic technologies, working in collaboration with research facilities to diagnose patients.

ORPHANET JOURNAL OF RARE DISEASES (2022)

Review Genetics & Heredity

A guide for the diagnosis of rare and undiagnosed disease: beyond the exome

Shruti Marwaha et al.

Summary: Rare diseases affect hundreds of millions of people worldwide, with traditional diagnostic techniques often failing to provide accurate diagnoses. New technologies such as whole genome sequencing and transcriptomics offer additional benefits in diagnosing undiagnosed patients. This review discusses the potential of these technologies, as well as computational methods and automation in genomic analysis.

GENOME MEDICINE (2022)

Article Biochemistry & Molecular Biology

Whole exome and genome sequencing in mendelian disorders: a diagnostic and health economic analysis

Lisa J. Ewans et al.

Summary: Whole genome sequencing (WGS) has a higher diagnostic rate compared to whole exome sequencing (WES) in suspected Mendelian disorder cases. However, the specific diagnostic yield and associated costs are still uncertain. This study investigates the differences in diagnostic and cost outcomes between WGS and WES in a cohort of families with suspected Mendelian disorders. The results show that WGS diagnosed 34% of WES-negative families, but subsequent WES reanalysis would have diagnosed 18% of these families, resulting in a WGS-specific diagnostic yield of 19% for the remaining families. The cost of WGS for additional diagnoses is higher compared to WES reanalysis.

EUROPEAN JOURNAL OF HUMAN GENETICS (2022)

Review Biochemistry & Molecular Biology

New Developments and Possibilities in Reanalysis and Reinterpretation of Whole Exome Sequencing Datasets for Unsolved Rare Diseases Using Machine Learning Approaches

Samarth Thonta Setty et al.

Summary: This article reviews the latest developments in using machine learning methods to discover the genetic causes of rare diseases, and provides detailed methods for reanalyzing unsolved rare diseases to solve associated problems.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Health Care Sciences & Services

Receiving Genomic Sequencing Results through the Victorian Undiagnosed Disease Program: Exploring Parental Experiences

Jo Martinussen et al.

Summary: This study explored the experiences of parents participating in the Victorian Undiagnosed Disease Program (UDP-Vic) and the impact of receiving diagnostic and non-diagnostic genomic sequencing results for their children. The findings revealed five shared themes among the parents, including searching for a diagnosis, varied impact of receiving a result, feelings of relief and disappointment, seeking connection, and moving towards acceptance.

JOURNAL OF PERSONALIZED MEDICINE (2022)

Article Genetics & Heredity

The Korean undiagnosed diseases program phase I: expansion of the nationwide network and the development of long-term infrastructure

Soo Yeon Kim et al.

Summary: The Phase I of the Korean Undiagnosed Diseases Program aimed to solve the problem of undiagnosed patients and develop infrastructure for translational research. During this phase, 458 patients were enrolled and classified into 3 groups. The diagnostic yield was 52.8%, with 242 patients obtaining a confirmative diagnosis.

ORPHANET JOURNAL OF RARE DISEASES (2022)

Article Multidisciplinary Sciences

Investigating disparity in access to Australian clinical genetic health services for Aboriginal and Torres Strait Islander people

Joanne Luke et al.

Summary: Research shows disparities in access to clinical genetic health services for Aboriginal and/or Torres Strait Islander people in Australia, with fewer appointments scheduled and lower attendance rates. These findings provide important baseline data on disparities in access to clinical genomics in Australia.

NATURE COMMUNICATIONS (2022)

Review Genetics & Heredity

Care4Rare Canada: Outcomes from a decade of network science for rare disease gene discovery

Kym M. Boycott et al.

Summary: The past decade has seen significant advancements in rare disease (RD) research, particularly in the field of genome-wide sequencing. The Care4Rare Canada Consortium has played a major role in identifying the molecular causes of unsolved RDs using exome and genome sequencing, achieving a high diagnostic success rate. The Consortium has also contributed to the development of data sharing platforms and catalyzed functional characterization research of novel genes. However, the challenge of solving all RDs remains, and further efforts are needed in leveraging clinical and 'omic data, exploring new technologies, and optimizing research protocols.

AMERICAN JOURNAL OF HUMAN GENETICS (2022)

Article Pediatrics

Singapore Undiagnosed Disease Program: Genomic Analysis aids Diagnosis and Clinical Management

Neha S. Bhatia et al.

Summary: Using NGS technology, particularly WES or WGS, can improve diagnostic yield in patients with suspected genetic disorders in the Asian setting. Trio sequencing shows higher diagnostic yield for certain phenotypes, and positive results can lead to changes in patient treatment.

ARCHIVES OF DISEASE IN CHILDHOOD (2021)

Article Genetics & Heredity

Clinical sites of the Undiagnosed Diseases Network: unique contributions to genomic medicine and science

Kelly Schoch et al.

Summary: The study evaluates the contributions of UDN clinical sites in diagnosing patients with undiagnosed diseases, demonstrating significant improvements in diagnosis rates and new disease gene discoveries.

GENETICS IN MEDICINE (2021)

Review Pediatrics

The influence of social determinants of health on the genetic diagnostic odyssey: who remains undiagnosed, why, and to what effect?

Yarden S. Fraiman et al.

Summary: Despite Mendelian genetic disorders being individually rare, they are collectively more common and contribute significantly to pediatric morbidity and mortality. Advancements in genetic testing have allowed for individualized treatment plans and could potentially improve quality of life, but ensuring equitable access remains a challenge. Further research is needed to address disparities in pediatric genetic testing and to provide precision medicine to all who can benefit.

PEDIATRIC RESEARCH (2021)

Article Genetics & Heredity

Commonalities across computational workflows for uncovering explanatory variants in undiagnosed cases

Shilpa Nadimpalli Kobren et al.

Summary: Genomic sequencing has become a powerful tool for discovering genetic abnormalities underlying rare Mendelian conditions. This study found that while well-established practices exist for initial steps in variant calling and quality control, there is substantial divergence in later stages for variant prioritization and multimodal data integration across different sites. The differences suggest that advancements in structural variant detection, noncoding variant interpretation, and integration of additional biomedical data could be especially promising for solving chronically undiagnosed cases.

GENETICS IN MEDICINE (2021)

Article Medicine, General & Internal

100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care - Preliminary Report

Damian Smedley et al.

Summary: The pilot study, involving 4660 participants with rare diseases, provided actionable diagnoses and identified three newly implicated disease genes, offering a road map for the larger implementation of genome sequencing in the setting of a national health service.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Pediatrics

Paediatric genomic testing: Navigating medicare rebatable genomic testing

Rani Sachdev et al.

Summary: Genomic testing for genetic diagnosis is becoming standard care for many children, now available for paediatricians to order for eligible children; it may increase genetic diagnoses but also yield more variants, incidental findings, and negative results.

JOURNAL OF PAEDIATRICS AND CHILD HEALTH (2021)

Article Genetics & Heredity

Integration of whole genome sequencing into a healthcare setting: high diagnostic rates across multiple clinical entities in 3219 rare disease patients

Henrik Stranneheim et al.

Summary: The study reports findings from whole genome sequencing of 4437 individuals at the Genomic Medicine Center Karolinska-Rare Diseases (GMCK-RD) since mid-2015, leading to molecular diagnoses for a portion of patients. Information sharing between teams was beneficial in clinical practice. Additionally, research resulted in the discovery of 17 new disease-causing genes.

GENOME MEDICINE (2021)

Editorial Material Biochemistry & Molecular Biology

Solve-RD: systematic pan-European data sharing and collaborative analysis to solve rare diseases

Birte Zurek et al.

Summary: Solve-RD is a groundbreaking EU project that brings together rare disease experts to actively share and analyze patient data, aiming to solve unsolved rare diseases through innovative clinical research methods. The project has already seen success in diagnosing cases through massive data re-analysis and novel -omics approaches.

EUROPEAN JOURNAL OF HUMAN GENETICS (2021)

Article Biochemistry & Molecular Biology

Solving patients with rare diseases through programmatic reanalysis of genome-phenome data

Leslie Matalonga et al.

Summary: Reanalysis of inconclusive exome/genome sequencing data can increase the diagnosis yield of patients with rare diseases, but the cost and effort required for reanalysis hinder its routine implementation. The Solve-RD project aims to uncover the molecular causes of undiagnosed rare diseases, successfully solving a portion of cases through innovative approaches to reanalyzing genomic data.

EUROPEAN JOURNAL OF HUMAN GENETICS (2021)

Review Genetics & Heredity

The clinical utility of exome and genome sequencing across clinical indications: a systematic review

Salma Shickh et al.

Summary: Exome/genome sequencing shows higher diagnostic yield compared to standard genetic tests, especially in neurological and acute indications. Diagnoses trigger various clinical management changes, but there is significant heterogeneity in study procedures and outcomes, limiting the certainty of available evidence for decision-making.

HUMAN GENETICS (2021)

Article Clinical Neurology

Diagnostic Yield of Whole Genome Sequencing After Nondiagnostic Exome Sequencing or Gene Panel in Developmental and Epileptic Encephalopathies

Elizabeth Emma Palmer et al.

Summary: In the study, whole genome sequencing (WGS) improved diagnostic yield over exome sequencing (ES) primarily through the detection of complex structural variants, and most diagnoses in patients were related to genes not included in the multigene panel (MGP). Additionally, autosomal recessive or X-chromosome linked diagnoses accounted for 42% of the total cases, highlighting the importance of further research in assessing the pathogenicity of novel variants in neurogenetic disorders such as DEE.

NEUROLOGY (2021)

Article Genetics & Heredity

The Canadian Rare Diseases Models and Mechanisms (RDMM) Network: Connecting Understudied Genes to Model Organisms

Kym M. Boycott et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2020)

Article Endocrinology & Metabolism

The Undiagnosed Diseases Network International: Five years and more!

D. Taruscio et al.

MOLECULAR GENETICS AND METABOLISM (2020)

Review Genetics & Heredity

New Diagnostic Approaches for Undiagnosed Rare Genetic Diseases

Taila Hartley et al.

ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, VOL 21, 2020 (2020)

Review Genetics & Heredity

Genomic Data Sharing for Novel Mendelian Disease Gene Discovery: The Matchmaker Exchange

Danielle R. Azzariti et al.

ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, VOL 21, 2020 (2020)

Review Pediatrics

Genomic Diagnosis for Pediatric Disorders: Revolution and Evolution

Emilie Lalonde et al.

FRONTIERS IN PEDIATRICS (2020)

Review Genetics & Heredity

Responsible, practical genomic data sharing that accelerates research

James Brian Byrd et al.

NATURE REVIEWS GENETICS (2020)

Editorial Material Biochemistry & Molecular Biology

A Diagnosis for All Rare Genetic Diseases: The Horizon and the Next Frontiers

Kym M. Boycott et al.

Article Genetics & Heredity

Cases from the Undiagnosed Diseases Network: The continued value of counseling skills in a new genomic era

Ellen F. Macnamara et al.

JOURNAL OF GENETIC COUNSELING (2019)

Article Genetics & Heredity

The Korean undiagnosed diseases program: lessons from a one-year pilot project

Soo Yeon Kim et al.

ORPHANET JOURNAL OF RARE DISEASES (2019)

Article Biochemistry & Molecular Biology

Unique bioinformatic approach and comprehensive reanalysis improve diagnostic yield of clinical exomes

Klaus Schmitz-Abe et al.

EUROPEAN JOURNAL OF HUMAN GENETICS (2019)

Review Genetics & Heredity

Case for genome sequencing in infants and children with rare, undiagnosed or genetic diseases

David Bick et al.

JOURNAL OF MEDICAL GENETICS (2019)

Article Medicine, General & Internal

Genomic medicine for undiagnosed diseases

Anastasia L. Wise et al.

LANCET (2019)

Article Pathology

Automated Clinical Exome Reanalysis Reveals Novel Diagnoses

Samuel W. Baker et al.

JOURNAL OF MOLECULAR DIAGNOSTICS (2019)

Article Health Care Sciences & Services

Characteristics of undiagnosed diseases network applicants: implications for referring providers

Nicole M. Walley et al.

BMC HEALTH SERVICES RESEARCH (2018)

Article Environmental Sciences

SpainUDP: The Spanish Undiagnosed Rare Diseases Program

Estrella Lopez-Martin et al.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2018)

Review Environmental Sciences

Meeting Patients' Right to the Correct Diagnosis: Ongoing International Initiatives on Undiagnosed Rare Diseases and Ethical and Social Issues

Sabina Gainotti et al.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2018)

Article Medicine, General & Internal

Effect of Genetic Diagnosis on Patients with Previously Undiagnosed Disease

K. Splinter et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Genetics & Heredity

Systematic reanalysis of clinical exome data yields additional diagnoses: implications for providers

Aaron M. Wenger et al.

GENETICS IN MEDICINE (2017)

Article Biochemistry & Molecular Biology

Japan's initiative on rare and undiagnosed diseases (IRUD): towards an end to the diagnostic odyssey

Takeya Adachi et al.

EUROPEAN JOURNAL OF HUMAN GENETICS (2017)

Article Genetics & Heredity

Clinical laboratories collaborate to resolve differences in variant interpretations submitted to ClinVar

Steven M. Harrison et al.

GENETICS IN MEDICINE (2017)

Article Genetics & Heredity

Initiating an undiagnosed diseases program in the Western Australian public health system

Gareth Baynam et al.

ORPHANET JOURNAL OF RARE DISEASES (2017)

Article Genetics & Heredity

The Undiagnosed Diseases Network: Accelerating Discovery about Health and Disease

Rachel B. Ramoni et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2017)

Article Endocrinology & Metabolism

The NIH Undiagnosed Diseases Program and Network: Applications to modern medicine

William A. Gahl et al.

MOLECULAR GENETICS AND METABOLISM (2016)

Article Multidisciplinary Sciences

Comment: The FAIR Guiding Principles for scientific data management and stewardship

Mark D. Wilkinson et al.

SCIENTIFIC DATA (2016)

Editorial Material Medicine, General & Internal

The Undiagnosed Diseases Network of the National Institutes of Health A National Extension

William A. Gahl et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)

Editorial Material Endocrinology & Metabolism

Undiagnosed Diseases Network International (UDNI): White paper for global actions to meet patient needs

Domenica Taruscio et al.

MOLECULAR GENETICS AND METABOLISM (2015)

Article Genetics & Heredity

FORGE Canada Consortium: Outcomes of a 2-Year National Rare-Disease Gene-Discovery Project

Chandree L. Beaulieu et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2014)

Article Genetics & Heredity

The National Institutes of Health Undiagnosed Diseases Program: insights into rare diseases

William A. Gahl et al.

GENETICS IN MEDICINE (2012)

Editorial Material Medicine, General & Internal

The NIH Undiagnosed Diseases Program Lessons Learned

William A. Gahl et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)